Meet Our Team

Rebecca Gwilt

Co-Founder & Managing Partner
Connect on LinkedIn 

Rebecca Gwilt launched Elevare Law to redefine legal partnerships for healthcare and technology innovators. With over a decade of experience advising pioneering digital health, AI, and virtual care companies, she blends deep regulatory expertise with a future-driven, business-first approach. From launch to exit, Rebecca provides strategic legal counsel that removes friction, mitigates risk, and accelerates growth.

Rebecca co-founded and led the country's first boutique healthcare innovation law firm for over a decade, guiding hundreds of companies through complex regulatory landscapes, helping them pivot, scale, innovate, and succeed. Prior to private practice, she worked with the U.S. Department of Health and Human Services (HHS) on the implementation of the Affordable Care Act and served as National Healthcare Policy Advisor at CGI, a global leader in health reform technology. These experiences shaped her commitment to legal counsel that is practical, proactive, policy-informed, and aligned with each client’s vision, budget, and goals.

At Elevare, Rebecca partners with healthcare visionaries, helping them anticipate challenges, seize opportunities, and build lasting impact. She believes legal should be more than risk management—it should be a catalyst for transformation.

Rebecca is also a passionate advocate for BIPOC and female founders, advising early stage companies, and mentoring startups through accelerators like Plug and Play, Texas Medical Center Innovations, and TechStars. A seeker of joy, investor in underestimated founders, karaoke samurai, expat adventurer, and kindness enthusiast, she lives in Lisbon, Portugal with her husband, three sons, and a playful bernedoodle named Sally.

Licensed In: Virginia

Check out these blogs written by 

Rebecca Gwilt

Legal + Regulatory
June 30, 2026
One Brief, Two Settlements, $6 Million: California's CPOM Trend is Real Now
At the start of May, we warned that the California Attorney General’s Brief in Art Center Holdings vs. MCE was a warning for healthcare companies structured as an MSO/PC. At the end of May, we told you that California was moving from warning to enforcement.
Legal + Regulatory
May 18, 2026
California Just Moved From Warning to Enforcement on MSO-PC Structures
What the Aspen Dental settlement, the AG's amicus brief, and the CMA's response mean for telehealth companies operating in California
Legal + Regulatory
May 7, 2026
The California AG Just Told You Which MSO-PC Contracts Are a Problem
"Wait—does this mean our continuity agreement is illegal?"
AI + Health Tech
March 25, 2026
The AI-Native Practice Is Here: Practitioners and Vendors Building the Future of Healthcare Together
After 10+ years advising digital health companies from both sides of the provider-vendor divide, I'm seeing something I've never seen before.
Legal + Regulatory
January 15, 2026
The FDA Exemptions Digital Health Companies Are Using to Skip Clearance in 2026 (Part Two: Clinical Decision Support Tools)
The digital health landscape is undergoing a seismic shift—and January 2026 marked a major milestone. The U.S. Food and Drug Administration (FDA) released two transformative guidance documents, one focused on Clinical Decision Support (CDS) software and the other on General Wellness Products.
Legal + Regulatory
January 12, 2026
The FDA Exemptions Digital Health Companies Are Using to Skip Clearance in 2026 (Part One: Wellness Products)
The digital health landscape is undergoing a seismic shift—and January 2026 marked a major milestone. The U.S. Food and Drug Administration (FDA) released two transformative guidance documents, one focused on Clinical Decision Support (CDS) software and the other on General Wellness Products.